Morning, Afternoon Exercise May Cut Diabetes Risk
TUESDAY, Sept. 26, 2023 (HealthDay News) -- Morning and afternoon physical activity are associated with a lower risk for developing type 2 diabetes, according to a study published online Sept. 20 in Diabetologia.
Caiwei Tian, from Harvard University in Cambridge, Massachusetts, and colleagues examined the relationship between morning, afternoon, or evening physical activity and consistency (e.g., routine) and the risk for type 2 diabetes. The analysis included data from 93,095 U.K. Biobank participants (mean age, 62 years) free from type 2 diabetes who wore a wrist-worn accelerometer for one week.
The researchers observed a protective association between morning and afternoon exercise with type 2 diabetes, with no differences between metabolic equivalent of task (MET)-measured morning and afternoon physical activity. When adjusting for lifestyle factors (e.g., sleep time and diet), the effect of a substitution between afternoon and evening physical activity was attenuated. There was no association seen for consistency of MET-measured physical activity and type 2 diabetes. At all times of day, moderate-to-vigorous and vigorous physical activity were associated with a lower risk for type 2 diabetes.
"The time of the day when being active may matter for mitigating the risk of type 2 diabetes, but overall physical activity, regardless of time of day and consistency, is the most important," the authors write.
Related Posts
El vapeo podría aumentar las probabilidades de uso de marihuana y atracones de bebida de los adolescentes
JUEVES, 18 de mayo de 2023 (HealthDay News) -- Es significativamente más...
Gun Homicides Rose Sharply During Pandemic, Black Men Most Affected
THURSDAY, Dec. 15, 2022 (HealthDay News) -- Gun deaths skyrocketed in the United...
Use of Vena Cava Filters in VTE Patients Is Safe, Effective
THURSDAY, March 16, 2023 (HealthDay News) -- Inferior vena cava filters (VCFs)...
Un nuevo medicamento podría aliviar los tics del Tourette en los niños y adolescentes
JUEVES, 31 de marzo de 2022 (HealthDay News) -- Un medicamento experimental se...